Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)

Neeraj Agarwal, Bradley McGregor, Benjamin L. Maughan, Tanya B. Dorff, William Kelly, Bruno Fang, Rana R. McKay, Parminder Singh, Lance Pagliaro, Robert Dreicer, Sandy Srinivas, Yohann Loriot, Ulka Vaishampayan, Sanjay Goel, Dominic Curran, Ashok Panneerselvam, Martin Schwickart, Toni K. Choueiri, Sumanta Pal

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)'. Together they form a unique fingerprint.

Medicine & Life Sciences